
SkinHealth Systems rose 1114.9% from $1.38 to a 1-year high of $16.77, ahead of the S&P 500's +10.5%. Its worst day was May 8 (−36.3%), and its low came Oct 12 at $0.53.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-1.20 beat the $-1.20 estimate on $82.4M revenue (est. $78.1M); FY revenue guidance of $285.0M–$305.0M against the $304.6M consensus.
+19.8% · S&P 500 −0.6%
Story events cover the past 12 months · Times ET
EPS of $-1.00 beat the $-1.60 estimate on $64.9M revenue (est. $66.3M); Q2 revenue guidance of $72.0M–$77.0M against the $76.4M consensus.
−36.3%, the year's worst day · S&P 500 +0.8%
EPS of $-0.40 beat the $-0.60 estimate on $72.1M revenue (est. $74.0M); Q3 revenue guidance of $65.0M–$70.0M against the $69.2M consensus.
−13.9% · S&P 500 +0.6%
SkinHealth Systems closed at its lowest level of the year, 62.0% below where the year started.
−4.5% · S&P 500 −0.1%
EPS of $-0.14 beat the $-0.26 estimate on $69.2M revenue (est. $67.9M); FY revenue guidance of $281.0M–$287.0M against the $284.6M consensus.
+51.8% · S&P 500 +0.3%
Where it ended: a 1-year high close of $16.77 on Nov 9, 2026.
Nothing in the past 12 months.
All SKIN dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SKIN and SPY from Benzinga historical bars. Not investment advice.